| General Information | |||
|---|---|---|---|
| Term | congenital bile acid synthesis defect 2 | ID (Ontology) | DOID:0111069 (Human Disease) |
| Definition | A congenital bile acid synthesis defect characterized by rapid progession of severe cholestatic liver disease, decreased levels of chenodeoxycholic acid and cholic acid in the serum and urine, and malabsorption of fat and fat-soluble vitamins that has_material_basis_in homozygous or compound heterozygous mutation in the AKR1D1 gene on chromosome 7q33. | ||
| Also Known As | "CBAS2" ; "cholestasis with delta(4)-3-oxosteroid 5-beta-reductase deficiency" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
physical disorder_____________________ steroid inherited metabolic disorder__| congenital bile acid synthesis defect |__congenital bile acid synthesis defect 2 3 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | congenital bile acid synthesis defect | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:10045 MESH:C535443 MIM:235555 ORDO:79303 SNOMEDCT_US_2023_03_01:238035000 UMLS_CUI:C1856127 |
|||